Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Artal International S.C.A.. Director active across 2 companies, notably Lexicon Pharmaceuticals, INC.. Cumulatively, 11 filings have been logged. Breakdown: 3 buys · 5 sells. Total volume traded: €2.3bn. History available since 1 August 2022. The latest transaction was filed on 18 November 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Artal International S.C.A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16,173,800 shares@ US$2.5017.4% of flowCommon StockSEC:0000899243-22-027156:0
Canonical exit: 30 Oct 2022 (T+90)
11 of 11 declarations
About Artal International S.C.A.
Artal International S.C.A. is a declarant with 11 filings in total. Across the 11 sampled filings, the period runs from 2022-08-01 to 2024-11-20, with EUR 112739589 of buys and EUR 2178731534 of sells, and the modal transaction nature is Sale. It is a Director of Cava Group, INC. on XNAS and a Director of Lexicon Pharmaceuticals, INC. on XNAS.